• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

COVID-19: another reason for anticoagulation in patients with atrial fibrillation.

作者信息

Raatikainen Pekka, Lassila Riitta

机构信息

Department of Cardiology, Heart and Lung Center, Helsinki University Hospital, Helsinki, Finland

Coagulation Disorders Unit, Department of Haematology, Comprehensive Cancer Center, Helsinki University Hospital, and Reserach Program Unit of Systems Oncology, University of Helsinki, Helsinki, Finland, Helsinki, Finland.

出版信息

Heart. 2022 May 25;108(12):902-904. doi: 10.1136/heartjnl-2022-320845.

DOI:10.1136/heartjnl-2022-320845
PMID:35314451
Abstract
摘要

相似文献

1
COVID-19: another reason for anticoagulation in patients with atrial fibrillation.新型冠状病毒肺炎：心房颤动患者抗凝治疗的又一原因。
Heart. 2022 May 25;108(12):902-904. doi: 10.1136/heartjnl-2022-320845.
2
Persisting stroke risk in patients with atrial fibrillation despite proper anticoagulation - Unmet clinical needs.尽管进行了适当的抗凝治疗，但心房颤动患者的中风风险仍然持续存在——未满足的临床需求。
Int J Cardiol. 2022 Dec 1;368:39-40. doi: 10.1016/j.ijcard.2022.08.019. Epub 2022 Aug 6.
3
The association of anticoagulation, ischemic stroke, and hemorrhage in elderly adults with chronic kidney disease and atrial fibrillation.老年慢性肾脏病合并心房颤动患者抗凝、缺血性卒中和出血的相关性。
Kidney Int. 2017 Apr;91(4):928-936. doi: 10.1016/j.kint.2016.10.017. Epub 2016 Dec 22.
4
Atrial fibrillation: Anticoagulation for AF: can we GRASP-AF patients?心房颤动：心房颤动的抗凝治疗：我们能掌握房颤患者的情况吗？
Nat Rev Cardiol. 2013 May;10(5):241-2. doi: 10.1038/nrcardio.2013.47. Epub 2013 Apr 2.
5
Prognostic Significance of Nuisance Bleeding in Anticoagulated Patients With Atrial Fibrillation.抗凝治疗的房颤患者非症状性出血的预后意义。
Circulation. 2018 Aug 28;138(9):889-897. doi: 10.1161/CIRCULATIONAHA.117.031354.
6
Balancing the benefits and risks of anticoagulation in patients with subclinical atrial fibrillation.平衡亚临床房颤患者抗凝治疗的获益与风险。
Eur Heart J. 2024 Mar 7;45(10):754-755. doi: 10.1093/eurheartj/ehad859.
7
MY APPROACH to the practical management of anticoagulation in patients with atrial fibrillation.我对心房颤动患者抗凝治疗实际管理的方法。
Trends Cardiovasc Med. 2016 Apr;26(3):292. doi: 10.1016/j.tcm.2015.05.022. Epub 2016 Jan 19.
8
Heart failure complicated by atrial fibrillation: How to make better choices for anticoagulation?心力衰竭合并心房颤动：如何做出更好的抗凝选择？
Int J Cardiol. 2024 Feb 15;397:131644. doi: 10.1016/j.ijcard.2023.131644. Epub 2023 Dec 6.
9
Fall risk and anticoagulation for atrial fibrillation in the elderly: A delicate balance.老年人房颤的跌倒风险与抗凝治疗：微妙的平衡。
Cleve Clin J Med. 2017 Jan;84(1):35-40. doi: 10.3949/ccjm.84a.16016.
10
An Update on Anticoagulation in Atrial Fibrillation.心房颤动抗凝治疗的最新进展
Heart Lung Circ. 2017 Sep;26(9):911-917. doi: 10.1016/j.hlc.2017.05.131. Epub 2017 Jun 3.

引用本文的文献

1
A Systematic Review of Case Reports of New-Onset Atrial Fibrillation in COVID-19 Patients.新型冠状病毒肺炎患者新发心房颤动病例报告的系统评价
Cureus. 2025 Feb 13;17(2):e78938. doi: 10.7759/cureus.78938. eCollection 2025 Feb.
2
COVID-19 Diagnosis, Oral Anticoagulation, and Stroke Risk in Patients with Atrial Fibrillation.COVID-19 诊断、口服抗凝药与房颤患者的卒中风险。
Am J Cardiovasc Drugs. 2024 Sep;24(5):693-702. doi: 10.1007/s40256-024-00671-3. Epub 2024 Aug 13.
3
COVID-19 pandemic and initiation of treatment for atrial fibrillation: a nationwide analysis of claims data.
COVID-19 大流行与心房颤动治疗的启动：一项全国性理赔数据分析。
BMC Cardiovasc Disord. 2023 Dec 8;23(1):604. doi: 10.1186/s12872-023-03614-z.
4
From post-COVID-19-associated myocarditis to hemopericardium: a dangerous domino effect.从新冠后相关心肌炎到心包积血：一种危险的多米诺效应。
J Geriatr Cardiol. 2023 May 28;20(5):391-396. doi: 10.26599/1671-5411.2023.05.008.
5
COVID-19 HEART unveiling as atrial fibrillation: pathophysiology, management and future directions for research.COVID-19引发的心脏问题表现为心房颤动：病理生理学、管理及未来研究方向
Egypt Heart J. 2023 Apr 30;75(1):36. doi: 10.1186/s43044-023-00359-0.
6
COVID-19 and atrial fibrillation: Intercepting lines.2019冠状病毒病与心房颤动：交叉防线
Front Cardiovasc Med. 2023 Jan 23;10:1093053. doi: 10.3389/fcvm.2023.1093053. eCollection 2023.